The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...
Life sciences expert Jennie Taveras has joined STO Building Group to lead the company’s growth in the life sciences sector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback